Obstructive sleep apnea (OSA) is already tied to heart disease, high blood pressure, and stroke. A new study adds cognition to that list — and finds the damage may begin decades before dementia would typically be diagnosed, while also offering evidence that treatment can blunt it.
The research, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association by a team from Monash University's Turner Institute for Brain and Mental Health, examined sleep apnea, memory, and dementia risk in adults who were still decades away from typical dementia onset — and found measurable differences tied to the sleep disorder even in this cognitively healthy group.
Studying Sleep Apnea Before Symptoms Emerge
Most research linking sleep apnea to dementia has focused on older adults who already show signs of cognitive decline, making it hard to know whether apnea contributes to that decline or simply accompanies it. The Monash team, led by PhD candidate Gabriel Abdelmessih, took a different approach, studying 2,795 cognitively unimpaired, middle-aged adults enrolled in Australia's Healthy Brain Project.
Participants self-reported whether they had obstructive sleep apnea and completed the Cogstate Brief Battery, a computerized cognitive test sensitive to subtle memory changes that wouldn't show up on standard clinical screening. Researchers also calculated each participant's Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score, a validated tool that estimates a person's future dementia risk based on midlife health measures.
Poorer Memory and Higher Risk Scores
Participants with OSA scored worse on memory testing than those without the condition, and this pattern held regardless of whether participants carried the APOE ε4 gene variant, the strongest known genetic risk factor for Alzheimer's disease. People with OSA also had significantly higher CAIDE dementia risk scores than those without either OSA or the APOE ε4 variant.
The memory association was attenuated, though not eliminated, after researchers statistically adjusted for vascular risk factors — a finding consistent with the idea that at least part of OSA's effect on the brain runs through cardiovascular pathways, such as blood pressure changes and oxygen fluctuations that strain blood vessels supplying the brain. Participants with OSA were also more likely to have obesity, high blood pressure, and high cholesterol, conditions that independently raise dementia risk and often cluster together with sleep apnea.
Managed Apnea Looked Different From Untreated Apnea
The more striking finding, highlighted in subsequent reporting on the study, was what happened among participants whose sleep apnea was being actively managed. Adults with treated OSA — most commonly using CPAP therapy, though weight loss, other lifestyle changes, and oral devices are also used to manage the condition — had cognitive test results statistically indistinguishable from adults who never had sleep apnea at all. The elevated risk pattern seen in untreated participants did not appear in this group.
That pattern doesn't prove treatment reverses cognitive risk, since the study measured apnea and treatment status at a single point in time rather than tracking the same patients before and after starting therapy. But it is consistent with a growing body of longitudinal research, including studies following patients for a decade or more, that has found CPAP use associated with slower cognitive decline over time in older adults with sleep apnea.
Why Midlife Matters
Dementia is now understood to develop over decades, with biological changes in the brain often beginning 15 to 20 years before diagnosis. That has shifted research attention toward midlife risk factors that might be modified before cognitive decline becomes clinically apparent — high blood pressure, hearing loss, physical inactivity, and, increasingly, sleep problems.
Sleep apnea is a particularly attractive target because it is common, frequently undiagnosed, and treatable. Estimates suggest a substantial share of middle-aged adults have OSA without knowing it, in part because classic symptoms like loud snoring and witnessed breathing pauses may go unnoticed by people who sleep alone or whose partners don't recognize the signs as medically significant.
What This Means for Patients
This study relied on self-reported OSA status rather than diagnostic sleep testing, and it captured a single snapshot in time rather than following participants as their apnea and cognition evolved — real limitations that keep it from proving cause and effect. Still, the pattern it describes is consistent with other research: sleep apnea's association with cognitive risk shows up even in people who feel cognitively fine, and that association looks meaningfully different in people whose apnea is being treated versus those whose apnea is not.
For adults in their 40s, 50s, and 60s — especially those with risk factors like obesity, high blood pressure, or high cholesterol who also snore heavily, feel unrefreshed after a full night's sleep, or have a partner who has noticed breathing pauses — this adds another reason to raise sleep apnea with a doctor rather than dismiss it as a minor inconvenience. Diagnosis and treatment are relatively accessible compared with most other dementia risk factors, and this research suggests the payoff may extend beyond the heart and into long-term brain health.
